Cipla Q1 results: Lower Covid-19 drug sales to hamper revenue growth
Cipla Q1 results: Lower Covid-19 drug sales to hamper revenue growth Cipla reported a net profit of Rs. 686.40 crores foe the quarter ended June 2022, slipped by 3.96% YoY from Rs. 714.72 crores. However, the net profit jumped … Continue reading Cipla Q1 results: Lower Covid-19 drug sales to hamper revenue growth
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed